Illustratively, as mentioned before, in the vascular studies, as a part of the severe vascular and multiorgan failure syndrome counteraction, there was counteraction of the brain, heart, lung, liver, kidney, and gastrointestinal lesions [18,19,23,24,27,28,29,31,37,38,39,40]
Clinical trials were conducted with imatinib, a PDGFR inhibitor, on patients with glioblastoma multiforme (GBM) who were refractory to chemotherapy and radiation therapy
10.1111/hel.12926 109 ZhaoK.XieQ.XuD.GuoY.TaoX.WeiH.et al (2018)
People with chronic bronchitis can also benefit from NAC
Peptides could potentially maintain disease control during treatment gaps, reducing the frequency and severity of flares that necessitate returning to stronger medications